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Periodontitis and type 2 diabetes 
among women with previous 
gestational diabetes: epidemiological 
and immunological aspects in a 
follow-up of three years
Periodontitis can contribute to the development of insulin resistance. 
Gestational diabetes is a risk factor for type 2 diabetes. Therefore, periodontitis, 
when associated with gestational diabetes, could increase the risk for the 
development of type 2 diabetes after pregnancy. Objective: The aim of this 
study was to verify the incidence on the development of type 2 diabetes in 
women with previous gestational diabetes with and without periodontitis 
after a three-year time interval. Material and Methods: Initial sample of this 
follow-up study consisted of 90 women diagnosed with gestational diabetes 
who underwent periodontal examination. After three years, 49 women were 
subjected to new periodontal examination and biological, behavioral, and 
???????????????????????????????????????????????????????????????????????????????
C-reactive protein in blood samples was performed. Fasting glucose and 
glycated hemoglobin levels were requested. Saliva samples were collected 
???????????????????????????????????????????????????????????????????????????
metalloproteinase 2 and 9. Results: The incidence of type 2 diabetes mellitus 
???? ?????? ???? ??? ?????????????? ???? ??????? ?????? ???? ??? ???????????
difference in the incidence of type 2 diabetes mellitus among women with 
and without periodontitis. It was observed impact of C-reactive protein in 
the development of type 2 diabetes mellitus. However, it was not observed 
impact of periodontitis on the development of type 2 diabetes mellitus among 
women with previous gestational diabetes. Conclusions: It was not observed 
impact of periodontitis on the development of type 2 diabetes among women 
with previous gestational diabetes. The impact of C-reactive protein in the 
development of type 2 diabetes mellitus highlights the importance of an 
?????????????????????????????????????????????????
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Introduction
?????????????????????????????????????????????????????
of periodontal tissues characterized by loss of tooth 
support1???????????????????????????????? ????????????
the pathogenesis of the disease called the attention to 
the systemic impact of periodontitis and its potential 
association with other conditions13.
Diabetes mellitus (DM) comprises a group of 
disorders characterized by high blood glucose levels, 
and it is considered an important risk factor for 
periodontitis2?????????????????????? ?????????????????
????????? ??? ???????????? ????? ??? ???? ????????? ????
prevalence, extension, and severity of periodontitis. On 
????????????????????????????????????????????????????
can contribute to a condition of insulin resistance, with 
impact on the glycemic control and manifestation of 
DM. The dissemination of bacteria and their products 
???????????????????????????????????????????????????
state that can initiate and propagate insulin resistance. 
??????????????????????????? ????????????????? tumor 
necrosis factor alpha (TNF-?), interleukin 6 (IL-
6), and C-reactive protein (CRP), might contribute 
to an increase in insulin resistance24. Additionally, 
periodontal bacteria can translocate to the liver, 
inhibit the insulin signaling, and result in decreased 
glycogen synthesis17. Recent systematic reviews have 
demonstrated that periodontal therapy can positively 
affect the control of DM11,22.
Gestational DM (GDM) is a hyperglycemic status 
????????????????????????????????????????????????????????
associated complications and high morbidity. An 
expressive risk for the development of DM type-2 (DM-
2) was reported among women with GDM. Therefore, 
the diagnosis of GDM constitutes an opportunity for 
early intervention of DM-22.
Based on the possibility that periodontitis can 
contribute to the development of insulin resistance, 
periodontitis, when present in women with GDM, could 
also increase the risk for the development of DM-2 
after the gestational period. To our knowledge, only 
one study evaluated the impact of periodontitis on 
the incidence of DM-2 among women with previous 
GDM, pointing out that women with a history of GDM 
and periodontitis have impaired glucose metabolism29. 
Therefore, additional studies are necessary to better 
address this potential association.
The aim of the present follow-up study was to verify 
the incidence on the development of type 2 diabetes 
in women with previous gestational diabetes with and 
without periodontitis after a three-year time interval, 
and to quantify CRP in the blood as well as TNF-?, 
IL-6, interleukin 10 (IL-10), matrix metalloproteinase 
2 (MMP-2), and matrix metalloproteinase 9 (MMP-9) 
in the saliva.
Material and methods
Sampling strategy
The sample of the present follow-up study initially 
comprised a cohort of 90 women previously diagnosed 
with GDM from a previous case-control study that 
investigated the association between periodontitis and 
GDM13. These women received prenatal care in the 
Odete Valadares Maternity Hospital, in Belo Horizonte 
city – Brazil, from February 2010 to November 2011, 
period when they were diagnosed with GDM.
Subsequently, these 90 women were invited to 
participate in the present study by phone or mail 
contact. From this total, 39 women could not be 
located and two refused to participate. Therefore, the 
????? ??????? ?????????? ?????????????? ?? ?????????
diagnosis of GDM.
The established inclusion criteria were the presence 
??????????????????????????????????????????????????????
for the periodontal examination. The exclusion criteria 
included antibiotic or periodontal therapy three months 
prior to clinical examination and positive human 
? ???????????????????????????????????????
The present study was approved by the Ethics 
Research Committee from the Federal University 
of Minas Gerais (CAAE 28708814.6.0000.5149). 
Participants were informed about the study and signed 
an informed consent form.
Sociodemographic characteristics
Social and demographic data were collected for 
each participant through structured questionnaires. 
We collected data regarding age, marital status, 
educational level, gestational period and delivery date, 
???????????????????????????????????????????????????????
???? ?????????? ???????????????????? ?????????? ???
smokers, former smokers, and non-smokers25.
Medical data
Weight and height of participants were recorded 
and body mass index (BMI) was calculated. According 
???????? ????? ?????????????????????????????????????
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weight, overweight, or obese27.
Fasting glucose test and glycated hemoglobin 
levels were collected for each participant. When exams 
showed altered glycemic levels, they were performed 
?????????????????????????????????????????????????????
than 125 mg/dl for fasting glucose and 6.4% for 
glycated hemoglobin were considered positive for the 
diagnosis of DM-2. Pre-diabetes was diagnosed as the 
presence of values higher than 99 mg/dl for fasting 
glucose and 5.6% for glycated hemoglobin, according 
to the American Diabetes Association2 (2014). Sample 
was divided in two groups according to glycemic levels: 
a) normal fasting glucose group (NFG); b) altered 
fasting glucose group (AFG). Subsequently, they were 
subdivided in three groups according to glycemic 
diagnosis: normal, pre-diabetes, and DM-2.
Additionally, we requested a blood test for assessing 
the CRP levels. The CRP level less than 5 mg/l was 
considered normal. Values greater than or equal to 5 
mg/l were considered abnormal20.
Periodontal clinical examination
Participants underwent a periodontal examination 
during gestation in a previous study13, determined to 
be the baseline examination (T0), when parameters 
of bleeding on probing (BOP), probing depth (PD), 
and clinical attachment level (CAL) were evaluated. 
At T0, the prevalence of periodontitis was 40% among 
women with GDM13.
Participants underwent a new periodontal 
examination after a period of approximately three 
years after delivery (34.5±6.4 months), determined 
???????????????????????????????????????????????????
comprised circumferential probing with the recording 
of periodontal parameters at four sites per tooth 
(distal, mesial, buccal, and lingual) with a manual 
probe (UNC-15, Hu-Friedy, Chicago, IL). Periodontal 
examinations were performed by a single periodontist 
(R.P.E.L.), trained and calibrated, responsible for the 
initial examination of the participants. Intra-examiner 
agreement for all clinical periodontal parameters of 
interest, both at T0 and T1, showed kappa values 
higher than 0.90.
All collected data were recorded and evaluated 
?????????????????????????????????????????????????????
The following exclusion criteria were also adopted 
during periodontal examination: third molars, teeth 
whose cementum-enamel junction was impossible to 
determine, teeth with gingival morphology alterations, 
teeth with extensive caries lesions, teeth with 
iatrogenic restorative procedures, excessive calculus 
presence.
???? ????????? ???? ?????????????? ?????????????? ????
???????????????????????????????????????????????? ??
?????????????????????????????????15. Periodontitis 
?????????????? ???????????????????????????????????????
the number of affected sites: 30% of sites (localized), 
and >30% of sites (generalized). Periodontitis was 
?????????????????????????????????????????????????????????
amount of attachment loss: 1-2 mm (slight form), 3-4 
????????????????????????????????????????????3.
Salivary examination
Stimulated whole saliva sample collections were 
performed to quantify the levels of IL-6, IL-10, 
MMP-2, MMP-9, and TNF-?. The collection of saliva 
was performed considering the period of two hours 
after the last meal. For the stimulus of the salivary 
???? the participants chewed the hyperboloid ????????
minutes and the saliva produced was collected on 
graph tubes. The saliva sample was kept in a cooler 
with ice and it was transported immediately to the 
laboratory where the total volume was registered 
and centrifuged at 3000 rpm for 15 minutes at 4°C. 
The volume was measured with a micropipette. After 
centrifuging, the saliva was diluted in the proportion of 
1:1 in PBS solution (0.4 mM NaCl and 10 mM NaPO4) 
containing protease inhibitors (0.1 mM phenyl methyl 
sulfonyl ???????, 0.1 mM benzethonium chloride, 10 
mM EDTA and 0.01 mg/mL aprotinin A). The solution 
was homogenized, distributed in aliquots, and froze 
at - 80°C to perform the analysis by ELISA. The 
concentrations of the cytokines IL-10, MMP-2, MMP-
9, and TNF-? in the saliva samples were determined 
by the sandwich technique using the DuoSet Kit (R&D 
Systems, Minneapolis, MN, USA). Detection limits were 
from 31.2 to 1000 pg/mL for TNF-?, 390-12500 pg/mL 
for MMP-9/TIMP2, 125-4000 pg/mL for MMP-2/TIMP2, 
and 125-2000 pg/mL for IL-10. The ????????????? of 
IL-6 was performed using the human IL-6 Kit and 
its quantikine (R&D Systems, Minneapolis, MN), with 
detection limits from 0.156 to 10 pg/mL. Techniques 
were performed according to the manufacturer’s 
?????????????? The concentrations were expressed in 
pg/mL. The concentration of total protein was used 
to correct the cytokine value for each sample. The 
corrected values were expressed as pg/mg.
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Statistical analysis
Initially, a descriptive analysis of the sample and 
a comparison of periodontal status between T0 and 
T1 were performed. For this purpose, the Wilcoxon 
test was used for quantitative variables and the 
McNemar or Stuart-Maxwell (for more than two levels 
of comparison) were used for categorical variables.
For the univariate analysis, considering the NFG 
and AFG groups, the Mann-Whitney and Kruskal-
Wallis tests were used for quantitative variables, and 
the Chi-squared or Fisher exact testes were used for 
?????????????????????????????????????????????????????
biological, behavioral, and social variables in alterations 
of fasting glucose and glycated hemoglobin exams was 
analyzed through a multinomial logistic regression. A 
?????????????????????????????????????????????????????
well as the biological plausibility, was adopted for the 
selection of variables to enter the models. All collected 
data were stored in a database (S1 Dataset), and 
all analyses were performed by means of statistical 
software (R version 3.0.1, R Foundation for Statistical 
Computing, Vienna, Austria). Results were considered 
????????????????????????????????????????????????????
Results
We present the characteristics of the sample 
according to biological, behavioral, and social variables 
for NFG and AFG groups in Table 1. We observed 
significant differences regarding mean BMI and 
glycemic values. Similar results were observed in the 
analysis of the biological, behavioral, and social data 
according to fasting glucose diagnosis at T1. There was 
a ????????????????????????????????? groups regarding 
mean BMI (p=0.014). The incidence of DM-2 was 
18.4%.
Table 2 shows ???? ????????????? of biochemical 
variables for NFG and AFG groups. We described 
CRP categorically and quantitatively. Important 
differences in the levels of CRP were observed between 
the groups. Approximately 53% of the AFG women 
demonstrated changes in CRP levels, while in the 
NFG group this percentage was 23.5% (p=0.040). 
When CRP was quantitatively evaluated, a higher 
average was observed in the AFG (p=0.077). There 
???? ???? ???? ??????????? ?????????? between groups 
for IL-6, IL-10, MMP-2, MMP-9, and TNF-? values. 
Similar results were observed for the analysis of the 
??????????????? ??? ????????????????????? in blood 
and saliva according to endocrine diagnosis. There 
was a difference between the groups regarding CRP 
described categorically.
We present periodontal status at T0 and T1 for NFG 
and AFG groups in Table 3. At T1, the frequency of 
periodontitis was higher in AFG group (46.7%) when 
compared with NFG group (35.3%). However, this 
??????????????? ???? ?????????????? ????????????whereas 
38.8% of the sample was diagnosed with periodontitis 
at T1. The incidence of periodontitis in AFG was 20%. 
??? ???? ????????? ?? ??????????? ??????????? ??????????
the number of teeth from T0 to T1 in the sample. 
However, this difference was not present when groups 
were compared. Women in the AFG group presented 
a higher percentage of sites with BOP and higher PD. 
From T0 to T1, women in the AFG group presented a 
????????????????????????????????????????????????????
??????????????????????????????????????????????????
sample concerning periodontal status at T0 and T1 
are presented in Table 4, according to the endocrine 
diagnosis???????? ??????????????????????????????????????
the frequency of periodontitis, as well as periodontal 
parameters, among the groups in both examinations.
We present changes in periodontal status from T0 
to T1, for both AFG and NFG groups, and according to 
the endocrine diagnosis, in Table 5. In the AFG group, 
the percentage of women who develop periodontitis 
between T0 and T1 was higher. In addition, women in 
the AFG group presented worse periodontal parameters 
from T0 to T1. The frequency of periodontitis at both 
T0 and T1, or only at T1, was higher among women 
diagnosed with pre-diabetes, although not statistically 
???????????? ?????????????????????????????????????
higher increase in PD from T0 to T1.
????????????????????????????????????????????????????
????? ???? ????????? ??? ?? ??????????? ???????? with 
glycemic control (OR 1.31; 95% CI=1.03-13.45; 
p=0.046). Similarly, the multinomial logistic regression 
model (considering the endocrine diagnosis) retained 
?????????????????????????????????????????????????????
p=0.022).
We also performed all analyses using glycated 
hemoglobin to establish the endocrine diagnosis. 
Similar results were observed using fasting glucose 
diagnosis. It is important to highlight that we observed 
?? ????? ???? ??????????? ?????????? ???????? ????????
glucose and glycated hemoglobin examinations (kappa 
0.841).
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Variable Glycemic control p
NFG (n=34; 69.4%) AFG (n=15; 30.6%)
CRP 0.040*
Normal 26 (76.5) 7 (46.7)
Altered 8 (23.5) 8 (53.3)
CRP (mg/l) 5.4 (10.4) 7.8 (7.9) 0.077**
IL-10 (pg/mg) 24.8 (61.5) 31.2 (68.0) 0.723**
MMP-9 (pg/mg) 1356.4 (1053.1) 1136.4 (986.0) 0.641**
MMP-2 (pg/mg) 126.8 (150.7) 156.8 (163.2) 0.494**
IL-6 (pg/mg) 55.3 (93.4) 41.6 (73.3) 0.956**
TNF-? (pg/mg) 32.8 (90.1) 27.8 (58.8) 0.312**
*Chi-squared test; **Mann-Whitney test; NFG = normal fasting glucose; AFG = altered fasting glucose; CRP = c-reactive protein; IL-6 = 
interleukin 6; IL-10 = interleukin 10; MMP-2 = matrix metalloproteinase 2; MMP-9 = matrix metalloproteinase 9; TNF-? = tumor necrosis 
fator alpha
Table 2-??????????????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????
control
Variables Total sample (n=49) Glycemic control p
NFG (n=34; 69.4%) AFG (n=15; 30.6%)
Age in years (±) 35.3 ± 5.1 34.9 ± 4.9 36.1 ± 5.4 0.317*
Marital status (%) 0.765**
with companion 41 (83.7%) 29 (85.3%) 12 (80.0%)
without companion 7 (14.3%) 4 (11.8%) 3 (20.0%)
Other 1 (2.0%) 1 (2.9%) 0 (0.0%)
Educational level (%) 0.482**
????????? 22 (44.9%) 14 (41.2%) 8 (53.3%)
From 9 to 12 years 25 (51.0%) 19 (55.9%) 6 (40.0%)
?????????? 2 (4.1%) 1 (2.9%) 1 (6.7%)
Parity (±) 2.4 (1.3) 2.4 (1.1) 2.2 (1.9) 0.136*
Time since delivery in 
months (±)
34.5 ± 6.4 34.1 ± 6.3 35.6 ± 6.8 0.467*
Smoking habits (%)
smoker 2 (4.1%) 2 (5.9%) 0 (0.0%) 1.000**
former smoker 8 (16.3%) 6 (17.2%) 2 (13.3%) 0.702**
Diabetes (%) 4 (8.2%) 0 (0.0%) 4 (28.6%) 0.005**
Family history of diabetes 
(%)
29 (59.2) 18 (52.9) 11 (73.3) 0.221**
BMI (%) 0.070**
adequate 13 (26.5) 12 (35.3) 1 (6.7)
overweight 16 (32.7) 11 (32.4) 5 (33.3)
obesity 20 (40.8) 11 (32.4) 9 (60.0)
BMI (mean) 30.3 (7.5) 28.6 (6.8) 33.9 (7.7) 0.014*
Fasting glucose (mean) 103 (33.6) 87.4 (7.5) 138.7 (42.2) 0.000*
Glycated hemoglobin 
(mean)
5.5 (1.1) 5.0 (1.0) 6.9 (1.0) 0.000*
*Mann-Whitney test; **Chi-squared test; NFG = normal fasting glucose; AFG = altered fasting glucose 
Table 1- Characteristics of the sample in relation to variables of interest according to glycemic control at T1
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Discussion
The biological plausibility? ????? ???? ????????????
process induced by periodontitis could contribute to 
insulin resistance, and DM-2 development can also be 
applied to GDM. The number of studies that evaluated 
the relationship between periodontitis and GDM is 
reduced4,5,9,13,28?? ????????????????????????????????????
are controversial. Some studies5,28 demonstrated that 
periodontitis was more frequent among women with 
GDM compared with women without GDM. However, 
other studies4,9,13 did not identify differences in the 
frequency of periodontitis among women with and 
without GDM. Important methodological differences, 
such as sample size and diagnostic criteria for 
?????????????? ???? ????? ??? ?????? ???? ????????? ????
comparisons of the results.
Findings from the present study demonstrated that 
the frequency of periodontitis was not higher among 
women with previous history of GDM that developed 
Variables Total sample n=49 (%) Glycemic control p
NFG n=34 (69.4%) AFG n=15 (30.6%)
Presence of periodontitis (%)
T0 20 (40.8) 16 (47.1) 4 (26.7) 0.221*
T1 19 (38.8) 12 (35.3) 7 (46.7) 0.451*
p 0.763*** 0.157*** 0.083***
Present teeth (±)
T0 27.5 (3.0) 27.3 (3.2) 27.9 (1.9) 0.635**
T1 27.1 (2.9) 26.9 (3.3) 27.7 (2.2) 0.515**
p 0.002**** 0.000**** 0.427****
Extension of periodontitis (%)
Localized T0 20 (40.8) 16 (47.1) 4 (26.7) 0.221*
Localized T1 17 (34.7) 11 (32.4) 6 (40.0) 0.741*
p 0.404*** 0.096*** 0.317***
Extension of periodontitis (%)
Generalized T0 0 (0.0) 0 (0.0) 0 (0.0) -
Generalized T1 2 (4.1) 1 (2.9) 1 (6.7) 0.489*
p 0.157*** 0.317*** 0.317***
Severity of periodontitis (%)
Moderate T0 1 (2.0) 1 (2.9) 0 (0.0) 1.000*
Moderate T1 3 (6.1) 2 (5.9) 1 (6.7) 1.000*
p 0.317*** 0.563*** 0.317***
Severity of periodontitis (%)
Advanced T0 19 (38.8) 15 (44.1) 4 (26.7) 0.341*
Advanced T1 16 (32.7) 10 (29.4) 6 (40.0) 0.515*
p 0.366*** 0.095*** 0.157***
Sites with BOP (%)
T0 22.9 (15.9) 22.6 (15.7) 23.6 (17.0) 0.905**
T1 32.5 (21.7) 29.8 (20.6) 38.5 (23.7) 0.121**
p 0.001**** 0.047**** 0.004****
????????????????????????????????????
T0
T1 2.8 (3.3) 2.9 (2.8) 2.7 (4.3) 0.314**
4.0 (5.7) 3.7 (5.1) 4.8 (7.1) 0.315**
p 0.067**** 0.3757**** 0.009****
???????????????????????????????????
(%)
T0 2.2 (3.3) 2.2 (3.1) 1.8 (2.5) 0.740**
T1 2.1 (5.7) 2.1 (4.2) 2.3 (3.9) 0.456**
p 0.876**** 0.868**** 0.683****
??????????????????????????????????
(%)
T0 0.1 (0.4) 0.2 (0.6) 0.1 (0.4) 0.178**
T1 0.1 (0.5) 0 (0.0) 0.1 (0.3) 0.635**
p 1.000**** 0.371**** 1.000****
*Chi-squared test; **Mann-Whitney test; ***McNemar test; ****Wilcoxon test; CAL = clinical attachment level; PD = probing depth; BOP = 
bleeding on probing; NFG = normal fasting glucose; AFG = altered fasting glucose
Table 3- Characteristics of the sample in relation to periodontal variables according to glycemic control at T0 and T1
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DM-2. A previous study29 evaluated the association 
between periodontitis and the DM-2 development 
among women with previous GDM. In this study 
from Xiong, et al.29 (2013), women with GDM and 
periodontitis were only compared with women without 
????? ??????????? ???? ??? ??????????? ?????????????????
found in the most glycemic indexes evaluated. In 
addition, the study presented lower sample and short 
follow-up period as well as it used glucose averages. 
In our understanding, it can interfere with the results, 
hindering the comparison with the present study. In 
addition, our results did not show any impact of the 
levels of IL-6, IL-10, MMP-2, MMP-9, and TNF-? in the 
saliva on DM-2 or pre-diabetes.
Some studies found that the treatment of 
periodontitis does not impact the metabolic control of 
individuals with DM-27,12. However, some systematic 
reviews and meta-analysis11,22,24???????????????????????
Variables Endocrine diagnosis p
Normal n=34 (69.4%) Pre-diabetes n=6 
(12.2%)
Type 2 diabetes n=9 
(18.4%)
Presence of periodontitis (%)
T0 16 (47.1) 2 (33.3) 2 (22.2) 0.451*
T1 12 (35.3) 4 (66.7) 3 (33.3) 0.316*
p 0.157*** 0.157*** 0.317***
Present teeth (±)
T0 27.3 (3.2) 28.7 (1.2) 27.4 (2.2) 0.548**
T1 26.9 (3.3) 28.3 (1.4) 27.2 (2.6) 0.626**
p 0.000**** 1.000**** 1.000****
Extension of periodontitis (%)
Localized T0 16 (47.1) 2 (33.3) 2 (22.2) 0.451**
Localized T1 11 (32.4) 4 (66.7) 2 (22.2) 0.221**
p 0.096*** 0.157*** 1.000***
Extension of periodontitis (%)
Generalized T0 0 (0.0) 0 (0.0) 0 (0.0)
Generalized T1 1 (2.9) 0 (0.0) 1 (11.1) 0.523**
p 0.317*** - 0.317***
Severity of periodontitis (%)
Moderate T0 1 (2.9) 0 (0.0) 0 (0.0) 1.000 **
Moderate T1 2 (5.9) 1 (16.7) 0 (0.0) 0.401**
p 0.563*** 0.317*** -
Severity of periodontitis (%)
Advanced T0 15 (44.1) 2 (33.3) 2 (22.2) 0.547**
Advanced T1 10 (29.4) 3 (50.0) 3 (33.3) 0.647**
P 0.095*** 0.317*** 0.317***
Sites with BOP (%)
T0 22.6 (15.7) 27.6 (16.7) 20.9 (17.7) 0.646**
T1 29.8 (20.6) 42.9 (19.0) 35.6 (27.1) 0.292**
p 0.047**** 0.094**** 0.024****
?????????????????????????????????
(%)
T0 2.9 (2.8) 2.6 (3.5) 2.7 (5.1) 0.590**
T1 3.7 (5.1) 4.4 (2.6) 5.1 (9.2) 0.224**
p 0.375**** 0.062**** 0.090****
???????????????????????????????????
(%)
T0 2.2 (3.1) 2.5 (3.2) 1.3 (1.9) 0.776**
T1 2.1 (4.2) 3.1 (3.7) 1.8 (4.1) 0.793**
p 0.868**** 0.787**** 1.000****
??????????????????????????????????
(%)
T0
T1 0.2 (0.6) 0 (0.0) 0 (0.0) 0.391**
0.1 (0.4) 0 (0.0) 0.1 (0.3) 0.191**
p 0.371**** - 1.000****
*Chi-squared test; **Kruskal-Wallis test; ***McNemar test; ****Wilcoxon test; CAL = clinical attachment level; PD = probing depth; BOP = 
bleeding on probing
Table 4- Characteristics of the sample in relation to periodontal variables according to endocrine diagnosis at T0 and T1
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effect of periodontal therapy on glycemic levels among 
individuals with DM-2.
Thus, it is important to emphasize that the fact that 
the sample included in our study presents, mostly, 
a more localized periodontitis could explain some 
divergences of results. We can also hypothesize that 
in a sample with a more generalized periodontitis, 
???????????????????????????????????????????????????
impact on insulin resistance and DM-2 development 
could be more evident. Although not statistically 
???????????? ????????????????? ???????? ????????? ???????
presented a worsening in periodontal status between 
both examinations. Findings showed an increase in the 
frequency, extension, and severity of periodontitis as 
well as in the percent of sites with BOP, PD, and CAL.
One study18 evaluated the effect of tooth extraction 
on glycemic control of individuals with DM-2, 
demonstrating that individuals undergoing dental 
????????????????????????????????????????????????????
hemoglobin levels compared with individuals who did 
not receive any treatment. ???????????????????????
?????????????? ????????? ? ????? ??? ???? ????????????
infectious process of the oral cavity in the metabolic 
control and the development of an insulin resistance.
?? ?????????????????????????????????????? ???????? 
were previously described. One systematic review8 
concluded that diabetic and non-diabetic individuals 
had similar levels of IL-6 in the saliva, suggesting a 
lack of association between IL-6 from ???????????????
process in the oral cavity and DM-2. In another 
study, the expression of IL-6, IL-10, and TNF-? in 
gingival tissues was similar in individuals with and 
without DM-210. Collin, et al.6 (2000) observed similar 
salivary levels of MMP-9 between diabetic and non-
diabetic individuals. Moreover, periodontal therapy 
has demonstrated the ability to reduce blood levels of 
CRP, as well as???????????? cytokines such as IL-6 
and TNF-?23.
Furthermore, we should consider the ?????????????
quantifying ???? ???????????? ??????? produced by 
periodontitis. The ??????????????????????? mediators 
present in the saliva provides a global measure of oral 
???????????. ?????????????????????????? present in 
the saliva mainly derive from the gingival crevicular 
?????? cells from other ??????????? processes of 
the oral cavity may be present, contributing to the 
overestimated inflammation from periodontitis. 
On the other hand, the dilution by the saliva may 
underestimate the ???????????????????????30.
Interestingly, in the current study, blood levels of 
???????????????????? ???????????????????????????? 
among women with a history of GDM. Another 
??????????????????? could be involved in these CRP 
levels, as well as other mediators ??? ???????????, 
contributing to the manifestation of DM-2. This fact 
may suggest the role of a ????????? ????????????
process in the development of insulin resistance. 
????????? ??????????? is ????????????? ???????? in 
Periodontitis and type 2 diabetes among women with previous gestational diabetes: epidemiological and immunological aspects in a follow-up of three years
Variable Fasting glucose p Endocrine diagnosis p
NFG AFG Normal Pre-diabetes Type 2 
diabetes
n=34 (69.4%) n=15 (30.6%) n=34 (69.4%) n=6 (12.2%) n=9 (18.4%)
Occurrence of periodontitis 
(T1–T0)
0.202* 0.339*
No T0 - No T1 16 (47.1) 8 (53.3) 16 (47.1) 2 (33.3) 6 (66.7)
No T0 - Yes T1 2 (5.9) 3 (20.0) 2 (5.9) 2 (33.3) 1 (11.1)
Yes T0 - Yes T1 10 (29.4) 4 (26.7) 10 (29.4) 2 (33.3) 2 (22.2)
Yes T0 - No T1 6 (17.6) 0 (0.0) 6 (17.6) 0 (0.0) 0 (0.0)
Mean of sites with BOP (%) 
(T1–T0)
7.2 (19.3) 15.0 (14.4) 0.121** 7.2 (19.3) 15.3 (17.3) 14.7 (13.3) 0.292**
????????????????????????????
4 mm (%) (T1–T0)
0.8 (4.0) 2.1 (3.5) 0.092** 0.8 (4.0) 1.8 (1.7) 2.4 (4.4) 0.224**
????????????????????????????
5-6 mm (%) (T1–T0)
- 0.1 (2.8) 0.6 (2.7) 0.532** - 0.1 (2.8) 0.7 (2.4) 0.5 (3.1) 0.793**
????????????????????????????
??????????????????????
- 0.1 (0.2) 0.1 (0.3) 0.111** - 0.1 (0.2) 0 (0.0) 0.1 (0.3) 0.191**
*Stuart-Maxwell test; **Wilcoxon test; CAL = clinical attachment level; PD = probing depth; BOP = bleeding on probing; NFG = normal 
fasting glucose; AFG = altered fasting glucose
Table 5- Characteristics of the sample in relation to periodontal variables according to glycemic control and endocrine diagnosis from T0 
to T1
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individuals with DM, including high levels of CRP17,24. 
A recent systematic review and meta-analysis26 
examined the association ????????????????????????
markers IL-6 and CRP and the risk of DM-2. Results 
showed ???????????????????????????????? high levels 
of IL-6 and CRP and the risk of DM-2, suggesting 
???? ???????????? ??????? as predictor of the DM-2 
development26. Similarly, women with GDM presented 
increased levels of CRP5,9. Furthermore, periodontitis 
has been associated with high CRP plasma levels14. This 
fact can support the biological plausibility of the impact 
of periodontal inflammation on DM-2. Therefore, 
different degrees of periodontitis may have different 
systemic repercussions.
The incidence of DM-2 among women with 
previous GDM was 18.4%. One study16 showed that 
38.8% of women with GDM presented pre-diabetes 
and 6.6% presented DM-2 in a period of 5.5 years. 
The systematic review by Kim, Newton and Knopp19 
(2002) showed a great variation in the incidence of 
DM-2 among women with history of GDM, from 2.6% 
to 70%. This great variability could be explained by 
differences in the follow-up period, in the diagnostic 
criteria for GDM, and in the sample selection.
Elevated BMI was significantly more frequent 
among women with altered glycemic levels, either 
diagnosed with pre-diabetes or DM-2, although it not 
???????????????????? ??? ???????????????????????????. 
Obesity has been considered a risk factor for DM-2 
development2. Studies investigating the association 
between periodontitis and GDM have demonstrated an 
elevated BMI associated with GDM4,5,9,13,28. Moreover, 
obesity has been associated with periodontitis21.
In the present study, increased age showed no 
impact on the development of DM-2 among women 
with GDM. Increased age has been considered a risk 
factor for GDM13. In addition, it was also demonstrated 
that the prevalence of DM-2 increased with age2. The 
history of GDM common to all individuals included 
in the present study may be a possible explanation 
????????????????????????????????????????????????????
groups. Sample size could be considered a limitation 
of the present study that may have contributed to 
????????????
Loss of participants due to non-location, non-
answer, or non-adherence could also be considered a 
limitation of the present study. From the 90 women 
enrolled in the initial sample, 49 completed the 
present study. The smaller sample due to the loss is a 
limitation; however, longitudinally, the results may be 
an important point of initial information on this issue, 
and thus directing future studies.
The period of three years follow-up after delivery 
for women with GDM is compatible according to the 
American Diabetes Association2. However, future 
studies may include longer periods of monitoring to 
?????????????????????????????
In the present study, there was not any impact 
of periodontitis on the DM-2 development among 
women with previous GDM. However, the number 
of studies on this subject is reduced. It is possible 
that, in other populations with different periodontal 
conditions, periodontitis may demonstrate impact on 
DM-2 development among women with previous GDM. 
Therefore, additional studies on different populations 
are necessary to better understand the relationship 
between these two conditions.
The improvement of the knowledge about GDM 
is important, since this condition can be considered 
a unique opportunity for a preventive intervention 
in relation to DM-2, a condition with high morbidity 
and mortality. The incidence of DM-2 among women 
with previous GDM observed in the present study was 
?????????????????????????????????????????????????????
???????????????????????????????????????????????????????
Conclusion
The observed impact of CRP on DM-2 development 
among women with a history of GDM demonstrates that 
during the prenatal monitoring period, it is necessary 
to emphasize the multidisciplinary approach for the 
diagnosis and treatment of ????????? ????????????
processes, minimizing the risk for developing an 
insulin resistance. U??????????????????? ???? ?????????
of periodontitis in the development of DM-2 among 
women with previous GDM do exist, signaling the need 
for additional studies.
References
1- Albandar JM. Global risk factors and risk indicators for periodontal 
diseases. Periodontol 2000. 2002;29:177-206.
??? ????????? ????????? ????????????? ?????????? ???? ?????????????? ???
diabetes mellitus. Diabetes Care. 2014;37:S81-90.
??????????????????????????????????????????????????????????????????????
diseases and conditions. Ann Periodontol. 1999;4:1-6.
4- Bullon P, Jaramillo R, Santos-Garcia R, Rios-Santos V, Ramirez M, 
Fernandez-Palacin A, et al. Relation of periodontitis and metabolic 
syndrome with gestational glucose metabolism disorder. J Periodontol. 
2014;85:e1-8.
ESTEVES LIMA RP, COTA LOM, SILVA TA, CORTELLI SC, CORTELLI JR, COSTA FO
2017;25(2):130-9
139J Appl Oral Sci.
5- Chokwiriyachit A, Dasanayake AP, Suwannarong W, Hormdee 
D, Sumanonta G, Prasertchareonsuk W, et al. Periodontitis and 
gestational diabetes mellitus in non-smoking females. J Periodontol. 
2013;84:857-62.
6- Collin HL, Sorsa T, Meurman JH, Niskanen L, Salo T, Rönkä H, et al. 
Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-
9) activities in patients with type 2 diabetes mellitus. J Periodontal 
Res. 2000;35:259-65.
7- Correa FO, Gonçalves D, Figueredo CM, Bastos AS, Gustafsson 
A, Orrico SR. Effect of periodontal treatment on metabolic control, 
?????????????????????????????????????????????????????????????????????
J Clin Periodontol. 2010;37:53-8.
8- Costa PP, Trevisan GL, Macedo GO, Palioto DB, Souza SL, Grisi 
MF, et al. Salivary interleukin-6, matrix metalloproteinase-8, and 
osteoprotegerin in patients with periodontitis and diabetes. J 
Periodontol. 2010;81:384-91.
9- Dasanayake AP, Chhun N, Tanner ACR, Craig RG, Lee MJ, Moore AF, 
et al. Periodontal pathogens and gestational diabetes mellitus. J Dent 
Res. 2008;87:328-33.
10- Duarte PM, Miranda TS, Lima JA, Dias Gonçalves TE, Santos VR, 
????????????????????????????????? ????????????????? ????????????????
of chronic periodontitis in patients with type 2 diabetes. J Periodontol. 
2012;83:426-34.
11- Engebretson S, Kocher T. Evidence that periodontal treatment 
improves diabetes outcomes: a systematic review and meta-analysis. 
J Periodontol. 2013;84:S53-69.
12- Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato 
MC, Hou W, et al. The effect of nonsurgical periodontal therapy on 
hemoglobin A1C levels in persons with type 2 diabetes and chronic 
periodontitis: a randomized clinical trial. JAMA. 2013;310:2523-32.
13- Esteves Lima RP, Miranda Cota LO, Costa FO. Association between 
periodontitis and gestational diabetes mellitus: a case-control study. J 
Periodontol. 2013;84:1257-65.
14- Gomes-Filho IS, Freitas Coelho JM, Cruz SS, Passos JS, Teixeira de 
Freitas CO, Aragão Farias NS, et al. Chronic periodontitis and C-reactive 
protein levels. J Periodontol. 2011;82:969-78.
15- Gomes-Filho IS, Cruz SS, Rezende EJ, Santos CA, Soledade 
KR, Magalhães MA, et al. Exposure measurement in the association 
between periodontal disease and prematurity/low birth weight. J Clin 
Periodontol. 2007;34:957-63.
16- Hummel S, Much D, Rossbauer M, Ziegler AG, Beyerlein A. 
Postpartum outcomes in women with gestational diabetes and their 
?????????????????????????????????????????????????????????????????????
2013;10:49-57.
17- Ishikawa M, Yoshida K, Okamura H, Ochiai K, Takamura H, Fujiwara 
N, et al. Oral Porphyromonas gingivalis translocates to the liver and 
??????????????????????????????????????????????????????????????????????
pathway. Biochim Biophys Acta. 2013;1832:2035-43.
Periodontitis and type 2 diabetes among women with previous gestational diabetes: epidemiological and immunological aspects in a follow-up of three years
18- Khader YS, Al Habashneh R, Al Malalheh M, Bataineh A. The effect 
of full-mouth tooth extraction on glycemic control among patients 
with type 2 diabetes requiring extraction of all remaining teeth: a 
randomized clinical trial. J Periodontol. 2010;45:741-7.
19- Kim C, Newton KM, Knopp RH. Gestational diabetes and the 
incidence of type 2 diabetes: a systematic review. Diabetes Care. 
2002;25:1862-8.
20- Ndrepepa G, Braun S, Cassese S, Fusaro M, King L, Kastrati A, et 
al. C-reactive protein and prognosis in women and men with coronary 
artery disease after percutaneous coronary intervention. Cardiovasc 
Revasc Med. 2013;14:264-9.
21- Pataro AL, Costa FO, Cortelli SC, Cortelli JR, Dupim Souza AC, 
???????????? ???????????? ????????????????????????????????????????????
surgery on the periodontal condition. J Periodontol. 2012;83:257-66.
22- Sgolastra F, Severino M, Pietropaoli D, Gatto R, Monaco A. 
Effectiveness of periodontal treatment to improve metabolic control in 
patients with chronic periodontitis and type 2 diabetes: a meta-analysis 
of randomized clinical trials. J Periodontol. 2013;84:958-73.
???????? ?????????????????????? ?????????????? ??? ???????????????
cytokines, adiponectin, insulin resistance and metabolic control after 
periodontal intervention in patients with type 2 diabetes and chronic 
periodontitis. Intern Med. 2011;50:1569-74.
24- Teeuw WJ, Gerdes VEA, Loos BG. Effect of periodontal treatment 
on glycemic control of diabetic patients: a systematic review and meta-
analysis. Diabetes Care. 2010;33:421-7.
25- Tomar SL, Asma S. Smoking-attributable periodontitis in the 
??????????????????????????????????????????????????????????????????????
Examination Survey. J Periodontol. 2000;71:743-51.
26- Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, et al. 
???????????????????? ???? ????? ??? ????? ?? ?????????????????????????
2013;36:166-75.
27- World Health Organization - WHO. The problem of overweight 
and obesity. Obesity: preventing and managing the global epidemic. 
In: ______. WHO technical report series number 894. Geneva: WHO; 
2000. p. 5-15.
28- Xiong X, Elkind-Hirsch KE, Vastardis S, Delarosa RL, Pridjian G, 
Buekens P. Periodontal disease is associated with gestational diabetes 
mellitus: a case-control study. J Periodontol. 2009;80:1742-9.
29- Xiong X, Elkind-Hirsch KE, Xie Y, Delarosa RL, Maney P, Pridjian G, et 
al. Periodontal disease as a potential risk factor for the development of 
diabetes in women with a prior history of gestational diabetes mellitus. 
J Public Health Dent. 2013;73:41-9.
?????????????????????????????????????????????????????????????????????
biomarkers in saliva: assessing the strength of association of diabetes 
????????????????????????????????????????????????????????????????????
Clin Periodontol. 2012;39:434-40.
2017;25(2):130-9
